Europe Molecular Diagnostics Market Forecast to 2030 – Regional Analysis – by Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others)
The Europe molecular diagnostics market is expected to grow from US$ 4,592.54 million in 2022 to US$ 11,225.77 million by 2030. It is estimated to grow at a CAGR of 11.8% from 2022 to 2030.
Surging Prevalence of Associated Diseases Fuels Europe Molecular Diagnostics Market
Molecular diagnostics procedures can be employed in the detection of a wide range of conditions such as oncologic diseases, infectious diseases, cardiac diseases, and immune system disorders; they can also be used in genetic testing using genetic material such as DNA and RNA for the diagnosis of different diseases. Cancer is one of the leading causes of death worldwide. The early detection of the disease can help prevent death among the patients. According to the data published by the UK.GOV on November 22, 2021, the infection rate of COVID-19 was ~422.7 per 100,000 population. Thus, the rising prevalence of target diseases fuels the molecular diagnostics market growth.
Europe Molecular Diagnostics Market Overview
The European molecular diagnostics market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global molecular diagnostics market and is expected to register a robust CAGR during 2022–2030. The market growth in Europe is attributed to growing life science research and an increase in government investment in testing infectious diseases.
Chronic diseases such as chronic obstructive pulmonary disease (COPD), diabetes, cancer, and arthritis can be life-threatening if left untreated. For instance, chronic lymphocytic leukemia (CLL) is the most common type of leukemia in Germany. According to the Deutsches Дrzteblatt, the prevalence of CLL in Germany stands at ~6 cases per 100,000; nearly 850 women and 1,000 men die from CLL every year.
Europe Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)
Europe Molecular Diagnostics Market Segmentation
The Europe molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.
Based on disease area, the Europe molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest Europe molecular diagnostics market share in 2022.
Based on technology, the Europe molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest Europe molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further sub segmented into RT-PCR, qPCR, multiplex PCR, and others.
Based on product and services, the Europe molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest Europe molecular diagnostics market share in 2022.
Based on end users, the Europe molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest Europe molecular diagnostics market share in 2022.
Based on country, the Europe molecular diagnostics market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe molecular diagnostics market in 2022.
Abbott Laboratories, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, bioMerieux SA, Illumina Inc, Danaher, Siemens Healthineers AG, and Novartis AG are some of the leading companies operating in the Europe molecular diagnostics market.
Surging Prevalence of Associated Diseases Fuels Europe Molecular Diagnostics Market
Molecular diagnostics procedures can be employed in the detection of a wide range of conditions such as oncologic diseases, infectious diseases, cardiac diseases, and immune system disorders; they can also be used in genetic testing using genetic material such as DNA and RNA for the diagnosis of different diseases. Cancer is one of the leading causes of death worldwide. The early detection of the disease can help prevent death among the patients. According to the data published by the UK.GOV on November 22, 2021, the infection rate of COVID-19 was ~422.7 per 100,000 population. Thus, the rising prevalence of target diseases fuels the molecular diagnostics market growth.
Europe Molecular Diagnostics Market Overview
The European molecular diagnostics market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global molecular diagnostics market and is expected to register a robust CAGR during 2022–2030. The market growth in Europe is attributed to growing life science research and an increase in government investment in testing infectious diseases.
Chronic diseases such as chronic obstructive pulmonary disease (COPD), diabetes, cancer, and arthritis can be life-threatening if left untreated. For instance, chronic lymphocytic leukemia (CLL) is the most common type of leukemia in Germany. According to the Deutsches Дrzteblatt, the prevalence of CLL in Germany stands at ~6 cases per 100,000; nearly 850 women and 1,000 men die from CLL every year.
Europe Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)
Europe Molecular Diagnostics Market Segmentation
The Europe molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.
Based on disease area, the Europe molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest Europe molecular diagnostics market share in 2022.
Based on technology, the Europe molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest Europe molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further sub segmented into RT-PCR, qPCR, multiplex PCR, and others.
Based on product and services, the Europe molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest Europe molecular diagnostics market share in 2022.
Based on end users, the Europe molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest Europe molecular diagnostics market share in 2022.
Based on country, the Europe molecular diagnostics market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe molecular diagnostics market in 2022.
Abbott Laboratories, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, bioMerieux SA, Illumina Inc, Danaher, Siemens Healthineers AG, and Novartis AG are some of the leading companies operating in the Europe molecular diagnostics market.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. EUROPE MOLECULAR DIAGNOSTICS MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
5. EUROPE MOLECULAR DIAGNOSTICS MARKET - KEY INDUSTRY DYNAMICS
5.1 Key Market Drivers:
5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
5.1.2 Surging Prevalence of Associated Diseases
5.2 Market Restraints
5.2.1 Limitations Associated with Molecular Testing
5.3 Market Opportunities
5.3.1 Advancements in Molecular Diagnostics Technologies
5.4 Future Trends
5.4.1 Molecular Diagnostics in Personalized Medicine
5.5 Impact Analysis:
6. MOLECULAR DIAGNOSTICS MARKET - EUROPE MARKET ANALYSIS
6.1 Europe Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030
7. EUROPE MOLECULAR DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY DISEASE AREA
7.1 Overview
7.2 Europe Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
7.3 Oncology
7.3.1 Overview
7.3.2 Oncology: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Infectious Disease
7.4.1 Overview
7.4.2 Infectious Disease: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Genetic Testing
7.5.1 Overview
7.5.2 Genetic Testing: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Cardiac Diseases
7.6.1 Overview
7.6.2 Cardiac Diseases: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Immune System Disorders
7.7.1 Overview
7.7.2 Immune System Disorders: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. EUROPE MOLECULAR DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY TECHNOLOGY
8.1 Overview
8.2 Europe Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Polymerase Chain Reaction
8.3.1 Overview
8.3.2 PCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 RT-PCR
8.3.2.1.1 Overview
8.3.3 RT-PCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.3.1 qPCR
8.3.3.1.1 Overview
8.3.4 qPCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.4.1 Multiplex PCR
8.3.4.1.1 Overview
8.3.5 Multiplex PCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.5.1 Others
8.3.5.1.1 Overview
8.3.6 Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.1 Overview
8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
8.5.1 Overview
8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 DNA Microarrays
8.6.1 Overview
8.6.2 DNA Microarrays: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 In-Situ Hybridization (ISH)
8.7.1 Overview
8.7.2 In-Situ Hybridization (ISH): Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. EUROPE MOLECULAR DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY PRODUCT AND SERVICES
9.1 Overview
9.2 Europe Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
9.3 Assays and Kits
9.3.1 Overview
9.3.2 Assays and Kits: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Instruments
9.4.1 Overview
9.4.2 Instruments: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Services and Software
9.5.1 Overview
9.5.2 Services and Software: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. EUROPE MOLECULAR DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY END USER
10.1 Overview
10.2 Europe Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Diagnostics Laboratories
10.4.1 Overview
10.4.2 Diagnostics Laboratories: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Research and Academic Institutes
10.5.1 Overview
10.5.2 Research and Academic Institutes: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11. EUROPE MOLECULAR DIAGNOSTICS MARKET - COUNTRY ANALYSIS
11.1 Europe Molecular Diagnostics Market, Revenue and Forecast to 2030
11.1.1 Overview
11.1.1.1 Europe Molecular Diagnostics Market by Country
11.1.2 Germany
11.1.2.1 Overview
11.1.3 Germany: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.4 Germany: Molecular Diagnostics Market, by Disease Area
11.1.5 Germany: Molecular Diagnostics Market, by Technology
11.1.5.1 Germany: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.6 Germany: Molecular Diagnostics Market, by Product and Services
11.1.7 Germany: Molecular Diagnostics Market, by End User
11.1.8 UK
11.1.8.1 Overview
11.1.9 UK : Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.10 UK: Molecular Diagnostics Market, by Disease Area
11.1.11 UK: Molecular Diagnostics Market, by Technology
11.1.11.1 UK: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.12 UK: Molecular Diagnostics Market, by Product and Services
11.1.13 UK: Molecular Diagnostics Market, by End User
11.1.14 France
11.1.14.1 Overview
11.1.15 France: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.16 France: Molecular Diagnostics Market, by Disease Area
11.1.17 France: Molecular Diagnostics Market, by Technology
11.1.17.1 France: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.18 France: Molecular Diagnostics Market, by Product and Services
11.1.19 France: Molecular Diagnostics Market, by End User
11.1.20 Italy
11.1.20.1 Overview
11.1.21 Italy: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.22 Italy: Molecular Diagnostics Market, by Disease Area
11.1.23 Italy: Molecular Diagnostics Market, by Technology
11.1.23.1 Italy: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.24 Italy: Molecular Diagnostics Market, by Product and Services
11.1.25 Italy: Molecular Diagnostics Market, by End User
11.1.26 Spain
11.1.26.1 Overview
11.1.27 Spain: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.28 Spain: Molecular Diagnostics Market, by Disease Area
11.1.29 Spain: Molecular Diagnostics Market, by Technology
11.1.29.1 Spain: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.29.1.1 Spain: Molecular Diagnostics Market, by Product and Services
11.1.30 Spain: Molecular Diagnostics Market, by End User
11.1.31 Rest of Europe
11.1.31.1 Overview
11.1.32 Rest of Europe: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.33 Rest of Europe: Molecular Diagnostics Market, by Disease Area
11.1.34 Rest of Europe: Molecular Diagnostics Market, by Technology
11.1.34.1 Rest of Europe: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.35 Rest of Europe: Molecular Diagnostics Market, by Product and Services
11.1.36 Rest of Europe: Molecular Diagnostics Market, by End User
12. EUROPE MOLECULAR DIAGNOSTICS MARKET INDUSTRY LANDSCAPE
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. EUROPE MOLECULAR DIAGNOSTICS MARKET, KEY COMPANY PROFILES
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Agilent Technologies Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Thermo Fisher Scientific Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Qiagen NV
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 bioMerieux SA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Illumina Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Danaher
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Siemens Healthineers AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Novartis AG
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About Us
14.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. EUROPE MOLECULAR DIAGNOSTICS MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
5. EUROPE MOLECULAR DIAGNOSTICS MARKET - KEY INDUSTRY DYNAMICS
5.1 Key Market Drivers:
5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
5.1.2 Surging Prevalence of Associated Diseases
5.2 Market Restraints
5.2.1 Limitations Associated with Molecular Testing
5.3 Market Opportunities
5.3.1 Advancements in Molecular Diagnostics Technologies
5.4 Future Trends
5.4.1 Molecular Diagnostics in Personalized Medicine
5.5 Impact Analysis:
6. MOLECULAR DIAGNOSTICS MARKET - EUROPE MARKET ANALYSIS
6.1 Europe Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030
7. EUROPE MOLECULAR DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY DISEASE AREA
7.1 Overview
7.2 Europe Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
7.3 Oncology
7.3.1 Overview
7.3.2 Oncology: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Infectious Disease
7.4.1 Overview
7.4.2 Infectious Disease: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Genetic Testing
7.5.1 Overview
7.5.2 Genetic Testing: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Cardiac Diseases
7.6.1 Overview
7.6.2 Cardiac Diseases: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Immune System Disorders
7.7.1 Overview
7.7.2 Immune System Disorders: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. EUROPE MOLECULAR DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY TECHNOLOGY
8.1 Overview
8.2 Europe Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Polymerase Chain Reaction
8.3.1 Overview
8.3.2 PCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 RT-PCR
8.3.2.1.1 Overview
8.3.3 RT-PCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.3.1 qPCR
8.3.3.1.1 Overview
8.3.4 qPCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.4.1 Multiplex PCR
8.3.4.1.1 Overview
8.3.5 Multiplex PCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.5.1 Others
8.3.5.1.1 Overview
8.3.6 Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.1 Overview
8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
8.5.1 Overview
8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 DNA Microarrays
8.6.1 Overview
8.6.2 DNA Microarrays: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 In-Situ Hybridization (ISH)
8.7.1 Overview
8.7.2 In-Situ Hybridization (ISH): Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. EUROPE MOLECULAR DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY PRODUCT AND SERVICES
9.1 Overview
9.2 Europe Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
9.3 Assays and Kits
9.3.1 Overview
9.3.2 Assays and Kits: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Instruments
9.4.1 Overview
9.4.2 Instruments: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Services and Software
9.5.1 Overview
9.5.2 Services and Software: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. EUROPE MOLECULAR DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY END USER
10.1 Overview
10.2 Europe Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Diagnostics Laboratories
10.4.1 Overview
10.4.2 Diagnostics Laboratories: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Research and Academic Institutes
10.5.1 Overview
10.5.2 Research and Academic Institutes: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11. EUROPE MOLECULAR DIAGNOSTICS MARKET - COUNTRY ANALYSIS
11.1 Europe Molecular Diagnostics Market, Revenue and Forecast to 2030
11.1.1 Overview
11.1.1.1 Europe Molecular Diagnostics Market by Country
11.1.2 Germany
11.1.2.1 Overview
11.1.3 Germany: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.4 Germany: Molecular Diagnostics Market, by Disease Area
11.1.5 Germany: Molecular Diagnostics Market, by Technology
11.1.5.1 Germany: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.6 Germany: Molecular Diagnostics Market, by Product and Services
11.1.7 Germany: Molecular Diagnostics Market, by End User
11.1.8 UK
11.1.8.1 Overview
11.1.9 UK : Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.10 UK: Molecular Diagnostics Market, by Disease Area
11.1.11 UK: Molecular Diagnostics Market, by Technology
11.1.11.1 UK: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.12 UK: Molecular Diagnostics Market, by Product and Services
11.1.13 UK: Molecular Diagnostics Market, by End User
11.1.14 France
11.1.14.1 Overview
11.1.15 France: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.16 France: Molecular Diagnostics Market, by Disease Area
11.1.17 France: Molecular Diagnostics Market, by Technology
11.1.17.1 France: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.18 France: Molecular Diagnostics Market, by Product and Services
11.1.19 France: Molecular Diagnostics Market, by End User
11.1.20 Italy
11.1.20.1 Overview
11.1.21 Italy: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.22 Italy: Molecular Diagnostics Market, by Disease Area
11.1.23 Italy: Molecular Diagnostics Market, by Technology
11.1.23.1 Italy: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.24 Italy: Molecular Diagnostics Market, by Product and Services
11.1.25 Italy: Molecular Diagnostics Market, by End User
11.1.26 Spain
11.1.26.1 Overview
11.1.27 Spain: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.28 Spain: Molecular Diagnostics Market, by Disease Area
11.1.29 Spain: Molecular Diagnostics Market, by Technology
11.1.29.1 Spain: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.29.1.1 Spain: Molecular Diagnostics Market, by Product and Services
11.1.30 Spain: Molecular Diagnostics Market, by End User
11.1.31 Rest of Europe
11.1.31.1 Overview
11.1.32 Rest of Europe: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.33 Rest of Europe: Molecular Diagnostics Market, by Disease Area
11.1.34 Rest of Europe: Molecular Diagnostics Market, by Technology
11.1.34.1 Rest of Europe: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.35 Rest of Europe: Molecular Diagnostics Market, by Product and Services
11.1.36 Rest of Europe: Molecular Diagnostics Market, by End User
12. EUROPE MOLECULAR DIAGNOSTICS MARKET INDUSTRY LANDSCAPE
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. EUROPE MOLECULAR DIAGNOSTICS MARKET, KEY COMPANY PROFILES
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Agilent Technologies Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Thermo Fisher Scientific Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Qiagen NV
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 bioMerieux SA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Illumina Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Danaher
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Siemens Healthineers AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Novartis AG
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About Us
14.2 Glossary of Terms
